You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial
|
|---|---|
| Published in |
The Lancet Respiratory Medicine, April 2024
|
| DOI | 10.1016/s2213-2600(24)00079-1 |
| Pubmed ID | |
| Authors |
John Lowe, David Gillespie, Ali Aboklaish, Tin Man Mandy Lau, Claudia Consoli, Malavika Babu, Mark Goddard, Kerenza Hood, Nigel Klein, Emma Thomas-Jones, Mark Turner, Marie Hubbard, Julian Marchesi, Janet Berrington, Sailesh Kotecha |
X Demographics
The data shown below were collected from the profiles of 38 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 14 | 37% |
| United States | 4 | 11% |
| Canada | 3 | 8% |
| Australia | 3 | 8% |
| Peru | 2 | 5% |
| Uganda | 1 | 3% |
| India | 1 | 3% |
| Saudi Arabia | 1 | 3% |
| El Salvador | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 7 | 18% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 22 | 58% |
| Scientists | 9 | 24% |
| Science communicators (journalists, bloggers, editors) | 4 | 11% |
| Practitioners (doctors, other healthcare professionals) | 3 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 1 | 100% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 1 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 88. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2024.
All research outputs
#496,908
of 25,870,940 outputs
Outputs from The Lancet Respiratory Medicine
#366
of 2,909 outputs
Outputs of similar age
#4,213
of 198,223 outputs
Outputs of similar age from The Lancet Respiratory Medicine
#5
of 34 outputs
Altmetric has tracked 25,870,940 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,909 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 76.8. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,223 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.